Impact of Recombinant Adenoviral Vectors on Liver Drug Metabolism
Author Information
Author(s): Shellie M Callahan, Piyanuch Wonganan, Maria A Croyle
Primary Institution: The University of Texas at Austin
Hypothesis
Long-term virus-induced alterations in CYP occur from changes initiated by the virus that may not be related to the immune response.
Conclusion
A single dose of recombinant adenovirus significantly suppresses CYP3A2 and CYP2C11 expression and function in male Sprague-Dawley rats for 14 days.
Supporting Evidence
- Wild type adenovirus suppressed CYP3A2 and CYP2C11 activity by 37% and 39% respectively within six hours.
- Levels of CYP3A2 and CYP2C11 fell to 67% and 79% of control by 14 days.
- Helper-dependent adenovirus suppressed CYP3A2 by 43% and CYP2C11 by 55% within six hours.
Takeaway
When rats were given a virus, it changed how their bodies processed drugs for a long time, even after the virus was gone.
Methodology
The study assessed enzyme activity, protein expression, and mRNA levels of CYP3A2 and CYP2C11 in male Sprague Dawley rats after administering various recombinant adenoviruses.
Potential Biases
Potential bias due to the use of a single animal model and the specific viral vectors tested.
Limitations
The study primarily focused on male Sprague-Dawley rats, which may limit the generalizability of the findings to other populations.
Participant Demographics
Male Sprague Dawley rats.
Statistical Information
P-Value
p ≤ 0.01
Statistical Significance
p ≤ 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website